Skip to main content
Erschienen in: CEN Case Reports 1/2013

01.05.2013 | Case Report

A case of secondary focal segmental glomerulosclerosis associated with malignant hypertension

verfasst von: Kumiko Fukuda, Akira Shimizu, Tomohiro Kaneko, Yukinari Masuda, Fumihiko Yasuda, Megumi Fukui, Seiichiro Higo, Akio Hirama, Akiko Mii, Shuichi Tsuruoka, Ryuji Ohashi, Yasuhiko Iino, Yuh Fukuda, Yasuo Katayama

Erschienen in: CEN Case Reports | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Focal segmental glomerulosclerosis (FSGS) is associated with various clinicopathological conditions, including hypertension. We report here a case of secondary FSGS associated with malignant hypertension. A 33-year-old man with a 1-month history of visual impairment and headache visited the Department of Ophthalmology at our hospital and was found to have hypertensive retinopathy and severe hypertension (230/160 mmHg). He was referred to our department based on suspected renal dysfunction. His blood pressure on admission was 250/130 mmHg. Physical examination and laboratory tests revealed hypertensive cardiac dysfunction, focal brain edema, renal dysfunction (serum creatinine, Cr 7.07 mg/dl, blood urea nitrogen, BUN 49.9 mg/dl), massive proteinuria (10.7 g/day), and thrombotic microangiopathy. Funduscopy showed exudate, hemorrhage, and papilledema. The cause of secondary hypertension could not be identified. He was treated for primary malignant hypertension, but required hemodialysis 3 days after admission due to anuria. Treatment with antihypertensive agents resulted in the gradual recovery of renal function, although heavy proteinuria continued with nephrotic syndrome. Renal biopsy performed 1 month after admission showed features of malignant nephrosclerosis with secondary FSGS. Hemodialysis was discontinued following further improvement in renal function and the most recent laboratory tests showed proteinuria 1.8 g/day and persistent renal dysfunction (BUN 36.5 mg/dl, Cr 3.14 mg/dl). Malignant hypertension may cause various injuries, including glomerular endothelial and epithelial cell injuries in glomerular hypertension and hyperfiltration, increase of the renin–angiotensin–aldosterone system, and endothelial–epithelial interaction, resulting in the development of secondary FSGS and heavy proteinuria.
Literatur
1.
Zurück zum Zitat Rosei EA, Salvetti M, Farsang C. Treatment of hypertensive urgencies and emergencies. Blood Press. 2006;15:255–6.PubMed Rosei EA, Salvetti M, Farsang C. Treatment of hypertensive urgencies and emergencies. Blood Press. 2006;15:255–6.PubMed
2.
Zurück zum Zitat Marik PE, Rivera R. Hypertensive emergencies: an update. Curr Opin Crit Care. 2011;17:569–80.CrossRefPubMed Marik PE, Rivera R. Hypertensive emergencies: an update. Curr Opin Crit Care. 2011;17:569–80.CrossRefPubMed
3.
Zurück zum Zitat Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H; Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res. 2009;32:3–107.PubMed Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G, Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K, Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Ueshima H, Umemura S, Ishimitsu T, Rakugi H; Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res. 2009;32:3–107.PubMed
4.
Zurück zum Zitat Olson JL. Renal disease caused by hypertension. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 937–90. Olson JL. Renal disease caused by hypertension. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2007. p. 937–90.
5.
Zurück zum Zitat D’Agati VD, Jennette JC, Silva FG. Hypertensive nephrosclerosis, renal artery stenosis, and atheroembolization. In: D’Agati VD, Jennette JC, Silva FG, editors. Atlas of nontumor pathology: non-neoplastic kidney diseases. Washington, DC: American Registry of Pathology; 2005. p. 425–546. D’Agati VD, Jennette JC, Silva FG. Hypertensive nephrosclerosis, renal artery stenosis, and atheroembolization. In: D’Agati VD, Jennette JC, Silva FG, editors. Atlas of nontumor pathology: non-neoplastic kidney diseases. Washington, DC: American Registry of Pathology; 2005. p. 425–546.
6.
Zurück zum Zitat Rennke HG, Klein PS. Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis. 1989;13:443–56.PubMed Rennke HG, Klein PS. Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis. 1989;13:443–56.PubMed
7.
Zurück zum Zitat D’Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004;43:368–82.CrossRefPubMed D’Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004;43:368–82.CrossRefPubMed
8.
Zurück zum Zitat Kuijpers MH, Gruys E. Spontaneous hypertension and hypertensive renal disease in the fawn-hooded rat. Br J Exp Pathol. 1984;65:181–90.PubMed Kuijpers MH, Gruys E. Spontaneous hypertension and hypertensive renal disease in the fawn-hooded rat. Br J Exp Pathol. 1984;65:181–90.PubMed
9.
Zurück zum Zitat Saito T, Sato H, Obara K, Yamakage K, Abe K, Furuyama T, Yoshinaga K. Progression of experimental focal glomerulosclerosis in the spontaneously hypertensive rat. J Lab Clin Med. 1990;115:165–73.PubMed Saito T, Sato H, Obara K, Yamakage K, Abe K, Furuyama T, Yoshinaga K. Progression of experimental focal glomerulosclerosis in the spontaneously hypertensive rat. J Lab Clin Med. 1990;115:165–73.PubMed
10.
Zurück zum Zitat Shimokama T, Haraoka S, Horiguchi H, Sugiyama F, Murakami K, Watanabe T. The Tsukuba hypertensive mouse (transgenic mouse carrying human genes for both renin and angiotensinogen) as a model of human malignant hypertension: development of lesions and morphometric analysis. Virchows Arch. 1998;432:169–75.CrossRefPubMed Shimokama T, Haraoka S, Horiguchi H, Sugiyama F, Murakami K, Watanabe T. The Tsukuba hypertensive mouse (transgenic mouse carrying human genes for both renin and angiotensinogen) as a model of human malignant hypertension: development of lesions and morphometric analysis. Virchows Arch. 1998;432:169–75.CrossRefPubMed
11.
Zurück zum Zitat Vernerová Z, Kujal P, Kramer HJ, Bäcker A, Cervenka L, Vanecková I. End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade. Physiol Res. 2009;58(Suppl 2):S69–78.PubMed Vernerová Z, Kujal P, Kramer HJ, Bäcker A, Cervenka L, Vanecková I. End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade. Physiol Res. 2009;58(Suppl 2):S69–78.PubMed
12.
Zurück zum Zitat Jones DB. Arterial and glomerular lesions associated with severe hypertension. Light and electron microscopic studies. Lab Invest. 1974;31:303–13.PubMed Jones DB. Arterial and glomerular lesions associated with severe hypertension. Light and electron microscopic studies. Lab Invest. 1974;31:303–13.PubMed
13.
Zurück zum Zitat Harvey JM, Howie AJ, Lee SJ, Newbold KM, Adu D, Michael J, Beevers DG. Renal biopsy findings in hypertensive patients with proteinuria. Lancet. 1992;340:1435–6.CrossRefPubMed Harvey JM, Howie AJ, Lee SJ, Newbold KM, Adu D, Michael J, Beevers DG. Renal biopsy findings in hypertensive patients with proteinuria. Lancet. 1992;340:1435–6.CrossRefPubMed
14.
Zurück zum Zitat Kadiri S, Thomas JO. Focal segmental glomerulosclerosis in malignant hypertension. S Afr Med J. 2002;92:303–5.PubMed Kadiri S, Thomas JO. Focal segmental glomerulosclerosis in malignant hypertension. S Afr Med J. 2002;92:303–5.PubMed
15.
Zurück zum Zitat Fujii S, Kasahara H, Oguchi H. A case of renovascular hypertension with nephrotic syndrome, accompanied by focal segmental glomerulosclerosis-like lesion in the contralateral kidney. Nihon Jinzo Gakkai Shi. 1991;33:1017–24 (Japanese).PubMed Fujii S, Kasahara H, Oguchi H. A case of renovascular hypertension with nephrotic syndrome, accompanied by focal segmental glomerulosclerosis-like lesion in the contralateral kidney. Nihon Jinzo Gakkai Shi. 1991;33:1017–24 (Japanese).PubMed
16.
Zurück zum Zitat Ubara Y, Hara S, Katori H, Yamada A, Morii H. Renovascular hypertension may cause nephrotic range proteinuria and focal glomerulosclerosis in contralateral kidney. Clin Nephrol. 1997;48:220–3.PubMed Ubara Y, Hara S, Katori H, Yamada A, Morii H. Renovascular hypertension may cause nephrotic range proteinuria and focal glomerulosclerosis in contralateral kidney. Clin Nephrol. 1997;48:220–3.PubMed
17.
Zurück zum Zitat Alkhunaizi AM, Chapman A. Renal artery stenosis and unilateral focal and segmental glomerulosclerosis. Am J Kidney Dis. 1997;29:936–41.CrossRefPubMed Alkhunaizi AM, Chapman A. Renal artery stenosis and unilateral focal and segmental glomerulosclerosis. Am J Kidney Dis. 1997;29:936–41.CrossRefPubMed
18.
Zurück zum Zitat Bhowmik D, Dash SC, Jain D, Agarwal SK, Tiwari SC, Dinda AK. Renal artery stenosis and focal segmental glomerulosclerosis in the contralateral kidney. Nephrol Dial Transplant. 1998;13:1562–4.CrossRefPubMed Bhowmik D, Dash SC, Jain D, Agarwal SK, Tiwari SC, Dinda AK. Renal artery stenosis and focal segmental glomerulosclerosis in the contralateral kidney. Nephrol Dial Transplant. 1998;13:1562–4.CrossRefPubMed
19.
Zurück zum Zitat Alchi B, Shirasaki A, Narita I, Nishi S, Ueno M, Saeki T, Miyamura S, Gejyo F. Renovascular hypertension: a unique cause of unilateral focal segmental glomerulosclerosis. Hypertens Res. 2006;29:203–7.CrossRefPubMed Alchi B, Shirasaki A, Narita I, Nishi S, Ueno M, Saeki T, Miyamura S, Gejyo F. Renovascular hypertension: a unique cause of unilateral focal segmental glomerulosclerosis. Hypertens Res. 2006;29:203–7.CrossRefPubMed
20.
Zurück zum Zitat Hijazi R, Chandar J, Nwobi O, Muneeruddin S, Zilleruelo G, Abitbol CL. Renal manifestations in toddlers with Takayasu’s arteritis and malignant hypertension. Pediatr Nephrol. 2009;24:1227–30.CrossRefPubMed Hijazi R, Chandar J, Nwobi O, Muneeruddin S, Zilleruelo G, Abitbol CL. Renal manifestations in toddlers with Takayasu’s arteritis and malignant hypertension. Pediatr Nephrol. 2009;24:1227–30.CrossRefPubMed
21.
Zurück zum Zitat Nagata M, Kriz W. Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int. 1992;42:148–60.CrossRefPubMed Nagata M, Kriz W. Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis. Kidney Int. 1992;42:148–60.CrossRefPubMed
22.
Zurück zum Zitat Rennke HG. How does glomerular epithelial cell injury contribute to progressive glomerular damage? Kidney Int Suppl. 1994;45:S58–63.CrossRefPubMed Rennke HG. How does glomerular epithelial cell injury contribute to progressive glomerular damage? Kidney Int Suppl. 1994;45:S58–63.CrossRefPubMed
23.
Zurück zum Zitat Kriz W, Kretzler M, Nagata M, Provoost AP, Shirato I, Uiker S, Sakai T, Lemley KV. A frequent pathway to glomerulosclerosis: deterioration of tuft architecture-podocyte damage-segmental sclerosis. Kidney Blood Press Res. 1996;19:245–53.CrossRefPubMed Kriz W, Kretzler M, Nagata M, Provoost AP, Shirato I, Uiker S, Sakai T, Lemley KV. A frequent pathway to glomerulosclerosis: deterioration of tuft architecture-podocyte damage-segmental sclerosis. Kidney Blood Press Res. 1996;19:245–53.CrossRefPubMed
24.
Zurück zum Zitat D’Agati VD. Podocyte injury in focal segmental glomerulosclerosis: lessons from animal models (a play in five acts). Kidney Int. 2008;73:399–406.CrossRefPubMed D’Agati VD. Podocyte injury in focal segmental glomerulosclerosis: lessons from animal models (a play in five acts). Kidney Int. 2008;73:399–406.CrossRefPubMed
25.
Zurück zum Zitat Thadhani R, Pascual M, Nickeleit V, Tolkoff-Rubin N, Colvin R. Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease. Lancet. 1996;347:231–3.CrossRefPubMed Thadhani R, Pascual M, Nickeleit V, Tolkoff-Rubin N, Colvin R. Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease. Lancet. 1996;347:231–3.CrossRefPubMed
26.
Zurück zum Zitat Durvasula RV, Shankland SJ. The renin–angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy. Curr Hypertens Rep. 2006;8:132–8.CrossRefPubMed Durvasula RV, Shankland SJ. The renin–angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy. Curr Hypertens Rep. 2006;8:132–8.CrossRefPubMed
27.
Zurück zum Zitat Suzuki K, Han GD, Miyauchi N, Hashimoto T, Nakatsue T, Fujioka Y, Koike H, Shimizu F, Kawachi H. Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. Am J Pathol. 2007;170:1841–53.CrossRefPubMed Suzuki K, Han GD, Miyauchi N, Hashimoto T, Nakatsue T, Fujioka Y, Koike H, Shimizu F, Kawachi H. Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. Am J Pathol. 2007;170:1841–53.CrossRefPubMed
28.
Zurück zum Zitat Sofue T, Kiyomoto H, Kobori H, Urushihara M, Nishijima Y, Kaifu K, Hara T, Matsumoto S, Ichimura A, Ohsaki H, Hitomi H, Kawachi H, Hayden MR, Whaley-Connell A, Sowers JR, Ito S, Kohno M, Nishiyama A. Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats. Am J Hypertens. 2012;25:604–11.CrossRefPubMed Sofue T, Kiyomoto H, Kobori H, Urushihara M, Nishijima Y, Kaifu K, Hara T, Matsumoto S, Ichimura A, Ohsaki H, Hitomi H, Kawachi H, Hayden MR, Whaley-Connell A, Sowers JR, Ito S, Kohno M, Nishiyama A. Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic rats. Am J Hypertens. 2012;25:604–11.CrossRefPubMed
29.
Zurück zum Zitat Ichihara A, Kobori H, Nishiyama A, Navar LG. Renal renin–angiotensin system. Contrib Nephrol. 2004;143:117–30.CrossRefPubMed Ichihara A, Kobori H, Nishiyama A, Navar LG. Renal renin–angiotensin system. Contrib Nephrol. 2004;143:117–30.CrossRefPubMed
30.
Zurück zum Zitat Fogo AB. Mechanisms in nephrosclerosis and hypertension—beyond hemodynamics. J Nephrol. 2001;14(Suppl 4):S63–9.PubMed Fogo AB. Mechanisms in nephrosclerosis and hypertension—beyond hemodynamics. J Nephrol. 2001;14(Suppl 4):S63–9.PubMed
31.
Zurück zum Zitat Hertig A, Rondeau E. Role of the coagulation/fibrinolysis system in fibrin-associated glomerular injury. J Am Soc Nephrol. 2004;15:844–53.CrossRefPubMed Hertig A, Rondeau E. Role of the coagulation/fibrinolysis system in fibrin-associated glomerular injury. J Am Soc Nephrol. 2004;15:844–53.CrossRefPubMed
32.
33.
Zurück zum Zitat Imakiire T, Kikuchi Y, Yamada M, Kushiyama T, Higashi K, Hyodo N, Yamamoto K, Oda T, Suzuki S, Miura S. Effects of renin–angiotensin system blockade on macrophage infiltration in patients with hypertensive nephrosclerosis. Hypertens Res. 2007;30:635–42.CrossRefPubMed Imakiire T, Kikuchi Y, Yamada M, Kushiyama T, Higashi K, Hyodo N, Yamamoto K, Oda T, Suzuki S, Miura S. Effects of renin–angiotensin system blockade on macrophage infiltration in patients with hypertensive nephrosclerosis. Hypertens Res. 2007;30:635–42.CrossRefPubMed
34.
Zurück zum Zitat Ikezumi Y, Suzuki T, Karasawa T, Kawachi H, Nikolic-Paterson DJ, Uchiyama M. Activated macrophages down-regulate podocyte nephrin and podocin expression via stress-activated protein kinases. Biochem Biophys Res Commun. 2008;376:706–11.CrossRefPubMed Ikezumi Y, Suzuki T, Karasawa T, Kawachi H, Nikolic-Paterson DJ, Uchiyama M. Activated macrophages down-regulate podocyte nephrin and podocin expression via stress-activated protein kinases. Biochem Biophys Res Commun. 2008;376:706–11.CrossRefPubMed
35.
36.
Zurück zum Zitat Matsumoto K, Fukuda N, Abe M, Fujita T. Dendritic cells and macrophages in kidney disease. Clin Exp Nephrol. 2010;14:1–11.CrossRefPubMed Matsumoto K, Fukuda N, Abe M, Fujita T. Dendritic cells and macrophages in kidney disease. Clin Exp Nephrol. 2010;14:1–11.CrossRefPubMed
37.
Zurück zum Zitat Hauser PV, Collino F, Bussolati B, Camussi G. Nephrin and endothelial injury. Curr Opin Nephrol Hypertens. 2009;18:3–8.CrossRefPubMed Hauser PV, Collino F, Bussolati B, Camussi G. Nephrin and endothelial injury. Curr Opin Nephrol Hypertens. 2009;18:3–8.CrossRefPubMed
38.
Zurück zum Zitat Henao DE, Saleem MA, Cadavid AP. Glomerular disturbances in preeclampsia: disruption between glomerular endothelium and podocyte symbiosis. Hypertens Pregnancy. 2010;29:10–20.CrossRefPubMed Henao DE, Saleem MA, Cadavid AP. Glomerular disturbances in preeclampsia: disruption between glomerular endothelium and podocyte symbiosis. Hypertens Pregnancy. 2010;29:10–20.CrossRefPubMed
Metadaten
Titel
A case of secondary focal segmental glomerulosclerosis associated with malignant hypertension
verfasst von
Kumiko Fukuda
Akira Shimizu
Tomohiro Kaneko
Yukinari Masuda
Fumihiko Yasuda
Megumi Fukui
Seiichiro Higo
Akio Hirama
Akiko Mii
Shuichi Tsuruoka
Ryuji Ohashi
Yasuhiko Iino
Yuh Fukuda
Yasuo Katayama
Publikationsdatum
01.05.2013
Verlag
Springer Japan
Erschienen in
CEN Case Reports / Ausgabe 1/2013
Elektronische ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-012-0041-2

Weitere Artikel der Ausgabe 1/2013

CEN Case Reports 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.